Korro Bio Statistics
Total Valuation
Korro Bio has a market cap or net worth of $246.29 million. The enterprise value is $118.96 million.
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Korro Bio has 9.37 million shares outstanding. The number of shares has increased by 31.62% in one year.
| Current Share Class | 9.37M |
| Shares Outstanding | 9.37M |
| Shares Change (YoY) | +31.62% |
| Shares Change (QoQ) | +3.52% |
| Owned by Insiders (%) | 6.43% |
| Owned by Institutions (%) | 60.87% |
| Float | 4.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.23, with a Debt / Equity ratio of 0.23.
| Current Ratio | 11.23 |
| Quick Ratio | 10.80 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.51% and return on invested capital (ROIC) is -38.78%.
| Return on Equity (ROE) | -74.51% |
| Return on Assets (ROA) | -35.27% |
| Return on Invested Capital (ROIC) | -38.78% |
| Return on Capital Employed (ROCE) | -41.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$860,863 |
| Employee Count | 102 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Korro Bio has paid $38,000 in taxes.
| Income Tax | 38,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -53.04% |
| 50-Day Moving Average | 38.00 |
| 200-Day Moving Average | 44.60 |
| Relative Strength Index (RSI) | 29.17 |
| Average Volume (20 Days) | 61,883 |
Short Selling Information
The latest short interest is 786,669, so 8.40% of the outstanding shares have been sold short.
| Short Interest | 786,669 |
| Short Previous Month | 751,589 |
| Short % of Shares Out | 8.40% |
| Short % of Float | 16.08% |
| Short Ratio (days to cover) | 9.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -95.76M |
| Pretax Income | -81.17M |
| Net Income | -87.81M |
| EBITDA | -92.47M |
| EBIT | -95.76M |
| Earnings Per Share (EPS) | -$11.11 |
Full Income StatementBalance Sheet
The company has $137.00 million in cash and $41.79 million in debt, giving a net cash position of $127.33 million or $13.59 per share.
| Cash & Cash Equivalents | 137.00M |
| Total Debt | 41.79M |
| Net Cash | 127.33M |
| Net Cash Per Share | $13.59 |
| Equity (Book Value) | 179.63M |
| Book Value Per Share | 19.28 |
| Working Capital | 139.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$73.69 million and capital expenditures -$18.11 million, giving a free cash flow of -$91.79 million.
| Operating Cash Flow | -73.69M |
| Capital Expenditures | -18.11M |
| Free Cash Flow | -91.79M |
| FCF Per Share | -$9.80 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |